Molecular Pathways: Can Activin-Like Kinase Pathway Inhibition Enhance the Limited Efficacy of VEGF Inhibitors?

Por Bhatt, Rupal S., Atkins, Michael B.
Publicado em 2014

Single lens to lens duplication: The missing link

Por Bhatt, Rupal, Jethani, Jitendra, Saluja, Praveen, Bharti, Vinay
Publicado em 2008

Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons

Por Bhatt, Rupal S., Tomoda, Toshifumi, Fang, Yin, Hatten, Mary E.
Publicado em 2000

Case of Basal Cell Carcinoma of the Prostate Successfully Treated Before and After a BRCA2 Reversion Mutation

Por Grossman, Joseph E., Wu, Yubo, Ye, Huihui, Bhatt, Rupal S.
Publicado no JCO Precis Oncol (2018)

Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic

Por Melms, Johannes C., Thummalapalli, Rohit, Shaw, Kristin, Ye, Huihui, Tsai, Leo, Bhatt, Rupal S., Izar, Benjamin
Publicado no J Immunother Cancer (2018)

Development and introduction of a communication skills module for postgraduate students of ophthalmology

Por Bhagat, Purvi R, Prajapati, Kamini M, Bhatt, Rupal B, Prajapati, Vipul K, Dureja, Rohit, Tank, Gunjan P
Publicado no Indian J Ophthalmol (2019)

Tumor Necrosis on Magnetic Resonance Imaging Correlates with Aggressive Histology and Disease Progression in Clear Cell Renal Cell Carcinoma

Por Beddy, Peter, Genega, Elizabeth M, Ngo, Long, Hindman, Nicole, Wei, Jesse, Bullock, Andrea, Bhatt, Rupal S, Atkins, Michael B, Pedrosa, Ivan
Publicado no Clin Genitourin Cancer (2013)

Hypoxia-inducible factor-2α: effect on radiation sensitivity and differential regulation by an mTOR inhibitor

Por Bhatt, Rupal S., Landis, Daniel M., Zimmer, Michael, Torregrossa, Joelle, Chen, Shaoyong, Sukhatme, Vikas P., Iliopoulos, Othon, Balk, Steve, Bubley, Glenn J.
Publicado em 2008

Selective spectroscopic imaging of hyperpolarized pyruvate and its metabolites using a single-echo variable phase advance method in balanced SSFP

Por Varma, Gopal, Wang, Xiaoen, Vinogradov, Elena, Bhatt, Rupal S., Sukhatme, Vikas, Seth, Pankaj, Lenkinski, Robert E., Alsop, David C., Grant, Aaron K.
Publicado no Magn Reson Med (2015)

Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signaling

Por Bhatt, Rupal S., Wang, Xiaoen, Zhang, Liang, Collins, Michael P., Signoretti, Sabina, Alsop, David C., Goldberg, S. Nahum, Atkins, Michael B., Mier, James W.
Publicado em 2010

High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma

Por Wang, Xiaoen, Zhang, Liang, Goldberg, S Nahum, Bhasin, Manoj, Brown, Victoria, Alsop, David C, Signoretti, Sabina, Mier, James W, Atkins, Michael B, Bhatt, Rupal S
Publicado em 2011

Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma

Por McKay, Rana R., Rodriguez, Gustavo E., Lin, Xun, Kaymakcalan, Marina D., Hamnvik, Ole-Petter R., Sabbisetti, Venkata S., Bhatt, Rupal S., Simantov, Ronit, Choueiri, Toni K.
Publicado no Clin Cancer Res (2015)

A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model

Por Hu, Junhui, Schokrpur, Shiruyeh, Archang, Maani, Hermann, Kip, Sharrow, Allison C., Khanna, Prateek, Novak, Jesse, Signoretti, Sabina, Bhatt, Rupal S., Knudsen, Beatrice S., Xu, Hua, Wu, Lily
Publicado no Mol Ther Methods Clin Dev (2018)

The Role of Angiopoietins as Potential Therapeutic Targets in Renal Cell Carcinoma()

Por Wang, Xiaoen, Bullock, Andrea J., Zhang, Liang, Wei, Lin, Yu, Dongyin, Mahagaokar, Kedar, Alsop, David C., Mier, James W., Atkins, Michael B., Coxon, Angela, Oliner, Jon, Bhatt, Rupal S.
Publicado em 2014

Early Actions of Anti–Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels

Por Sitohy, Basel, Chang, Sunghee, Sciuto, Tracey E., Masse, Elizabeth, Shen, Mei, Kang, Peter M., Jaminet, Shou-Ching, Benjamin, Laura E., Bhatt, Rupal S., Dvorak, Ann M., Nagy, Janice A., Dvorak, Harold F.
Publicado no Am J Pathol (2017)

Comprehensive genomic profiling of metastatic tumors in a phase II biomarker study of everolimus in advanced renal cell carcinoma

Por Gao, Xin, Jegede, Opeyemi, Gray, Connor, Catalano, Paul J., Novak, Jesse, Kwiatkowski, David J., McKay, Rana R., George, Daniel J., Choueiri, Toni K., McDermott, David F., Signoretti, Sabina, Bhatt, Rupal S.
Publicado no Clin Genitourin Cancer (2018)

Resistance of Renal Cell Carcinoma to Sorafenib Is Mediated by Potentially Reversible Gene Expression

Por Zhang, Liang, Bhasin, Manoj, Schor-Bardach, Rachel, Wang, Xiaoen, Collins, Michael P., Panka, David, Putheti, Prabhakar, Signoretti, Sabina, Alsop, David C., Libermann, Towia, Atkins, Michael B., Mier, James W., Goldberg, S. Nahum, Bhatt, Rupal S.
Publicado em 2011

Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma

Por Wang, Xiaoen, Solban, Nicolas, Khanna, Prateek, Callea, Marcella, Song, Jiaxi, Alsop, David C., Pearsall, R. Scott, Atkins, Michael B., Mier, James W., Signoretti, Sabina, Alimzhanov, Marat, Kumar, Ravi, Bhasin, Manoj K., Bhatt, Rupal S.
Publicado no Oncotarget (2016)

Phase II Study of Neoadjuvant Chemotherapy with Docetaxel and Bevacizumab in Patients with High-Risk Localized Prostate Cancer: A Prostate Cancer Clinical Trials Consortium Trial

Por Ross, Robert W, Galsky, Matthew D, Febbo, Phil, Barry, Marc, Richie, Jerome P, Xie, Wanling, Fennessy, Fiona M, Bhatt, Rupal, Hayes, Julia, Choueiri, Toni K, Tempany, Clare M, Taplin, Mary E, Oh, William K
Publicado em 2012

Angiogenic factor and cytokine analysis among patients treated with adjuvant VEGFR TKIs in resected renal cell carcinoma

Por Xu, Wenxin, Puligandla, Maneka, Manola, Judith, Bullock, Andrea J., Tamasauskas, Daniel, McDermott, David F., Atkins, Michael B., Haas, Naomi B., Flaherty, Keith, Uzzo, Robert G., Dutcher, Janice P., DiPaola, Robert S., Bhatt, Rupal S.
Publicado no Clin Cancer Res (2019)